Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-26 @ 10:19 PM
Ignite Modification Date: 2025-12-26 @ 10:19 PM
NCT ID: NCT01559012
Description: For 5 days the patient received TD clonidine, the other 5 days received placebo.
Frequency Threshold: 0
Time Frame: 10 days of hospital stay
Study: NCT01559012
Study Brief: Transdermal Clonidine in the Treatment of Severe Hyperemesis Gravidarum
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Clonidine patients are treated with transdermal clonidine patch 5 mg for 5 days None None 0 6 0 6 View
Placebo patients are treated with placebo (sham patch) for 5 days None None 0 7 1 7 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Itching NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View